Torrance, United States
Basepaws is a trailblazing pet genetics company that caters to pet parents seeking affordable and accessible health solutions for their animals. Specializing in early detection health risk tests informed by genetic and microbiome data, Basepaws places a significant emphasis on advancing companion animal health research. Notably, it introduced the world's first at-home genetic testing platform specifically for cats.
Founded by visionary entrepreneur Anna Skaya in 2017 and based in Los Angeles, CA, Basepaws caught the eye of industry leader Zoetis Inc., which completed its acquisition of the company on June 22, 2022. Although the financial details remain undisclosed, this acquisition underscores the strategic value Basepaws adds to Zoetis Inc.'s offerings.
On January 1, 2023, Basepaws secured a pivotal investment in its venture round from East Los Capital, indicating investor confidence in its growth trajectory within the biotechnology sector.
